Finance

Lists
A1LB34:BVMF
Albemarle Corp Bdr
R$22.55
-1.10%
(-0.25) 1D
Nov 9, 1:40:21 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for A1LB34...
Open
R$22.80
High
R$22.82
Low
R$22.48
Mkt. cap
11.79B
Avg. vol.
2.11K
Volume
229.00
52-wk high
R$44.96
52-wk low
R$19.20
Shares outstanding
118.01M
No. of employees
8K
Open
R$22.80
High
R$22.82
Low
R$22.48
Mkt. cap
11.79B
Avg. vol.
2.11K
Volume
229.00
52-wk high
R$44.96
52-wk low
R$19.20
Shares outstanding
118.01M
No. of employees
8K
News stories
From web sources and news partners
Profile
Albemarle Corporation is an American specialty chemicals and mining company headquartered in Charlotte, North Carolina. Its principal businesses produce lithium compounds used in electric-vehicle batteries and energy-storage systems, and bromine-based specialty chemicals, including flame retardants. The company traces its origins to the Albemarle Paper Manufacturing Company, founded in Richmond, Virginia, in 1887. The present company became an independent publicly traded corporation in 1994, when Ethyl Corporation spun off its specialty-chemicals business. In 2025, Albemarle reported net sales of approximately US$5.1 billion and approximately 7,800 employees, including employees of its consolidated joint ventures. Albemarle is one of the world's largest lithium producers. It extracts lithium from brine at the Salar de Atacama in Chile and at Silver Peak, Nevada. In 2025, commercial-scale lithium production in the United States came from a single continental-brine operation in Nevada. The company also holds interests in the Greenbushes and Wodgina hard-rock spodumene mines in Western Australia and operates lithium-conversion facilities in several countries. Wikipedia
About Albemarle Corp Bdr
CEOJ Kent Masters
Employees7.8K
FoundedFeb 28, 1994
Headquarters-
SectorMaterials
IndustrySpeciality chemicals
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.43B
1.43B
1.74B
1.55B
Cost of goods sold
1.23B
927.76M
1.15B
1.24B
Cost of revenue
1.23B
927.76M
1.15B
1.24B
Research and development expenses
12.18M
9.17M
3.67M
8.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158.24M
137.67M
107.46M
121.62M
Operating expense
170.42M
146.84M
111.13M
129.79M
Total operating expenses
1.40B
1.07B
1.26B
1.37B
Operating income
32.31M
354.13M
483.07M
182.33M
Other non operating income
179.27M
76.45M
14.50M
22.29M
EBT including unusual items
-244.43M
350.49M
593.21M
338.57M
EBT excluding unusual items
37.70M
465.38M
613.78M
381.72M
Income tax expense
157.33M
21.51M
94.00M
21.90M
Effective tax rate
-64.37%
6.14%
15.85%
6.47%
Other operating expenses
-
-
-
-
Net income
-414.18M
319.09M
479.96M
296.76M
Net profit margin
-29.00%
22.33%
27.53%
19.11%
Earnings per share
-0.53
2.95
3.75
2.58
Interest and investment income
-
-
-
-
Interest expense
-50.30M
-45.71M
-30.92M
-27.80M
Net interest expenses
-50.30M
-45.71M
-30.92M
-27.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
196.02M
511.94M
638.87M
350.74M
Gain or loss from assets sale
-
95.02M
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps